Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry

Hongwei Xie, Getiria Onsongo, Jonathan Popko, Ebbing P. de Jong, Jing Cao, John V. Carlis, Robert J. Griffin, Nelson L. Rhodus, Timothy J. Griffin

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Whole human saliva possesses tremendous potential in clinical diagnostics, particularly for conditions within the oral cavity such as oral cancer. Although many have studied the soluble fraction of whole saliva, few have taken advantage of the diagnostic potential of the cells present in saliva, and none have taken advantage of proteomics capabilities for their study. We report on a novel proteomics method with which we characterized for the first time cells contained in whole saliva from patients diagnosed with oral squamous cell carcinoma. Our method uses three dimensions of peptide fractionation, combining the following steps: preparative IEF using free flow electrophoresis, strong cation exchange step gradient chromatography, and microcapillary reverse-phase liquid chromatography. We determined that the whole saliva samples contained enough cells, mostly exfoliated epithelial cells, providing adequate amounts of total protein for proteomics analysis. From a mixture of four oral cancer patient samples, the analysis resulted in a catalogue of over 1000 human proteins, each identified from at least two peptides, including numerous proteins with a role in oral squamous cell carcinoma signaling and tumorigenesis pathways. Additionally proteins from over 30 different bacteria were identified, some of which putatively contribute to cancer development. The combination of preparative IEF followed by strong cation exchange chromatography effectively fractionated the complex peptide mixtures despite the closely related physiochemical peptide properties of these separations (pl and solution phase charge, respectively). Furthermore compared with our two-step method combining preparative IIEF and reverse-phase liquid chromatography, our three-step method identified significantly more cellular proteins while retaining higher confidence protein identification enabled by peptide pl information gained through IEF. Thus, for detecting salivary markers of oral cancer and possibly other conditions of the oral cavity, the results confirm both the potential of analyzing the cells in whole saliva and doing so with our proteomics method.

Original languageEnglish (US)
Pages (from-to)486-498
Number of pages13
JournalMolecular and Cellular Proteomics
Volume7
Issue number3
DOIs
StatePublished - Mar 1 2008

Fingerprint

Mouth Neoplasms
Fractionation
Tandem Mass Spectrometry
Saliva
Proteomics
Mass spectrometry
Peptides
Proteins
Liquid chromatography
Reverse-Phase Chromatography
Chromatography
Mouth
Cations
Squamous Cell Carcinoma
Cell signaling
Electrophoresis
Complex Mixtures
Bacteria
Carcinogenesis
Epithelial Cells

Cite this

Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. / Xie, Hongwei; Onsongo, Getiria; Popko, Jonathan; de Jong, Ebbing P.; Cao, Jing; Carlis, John V.; Griffin, Robert J.; Rhodus, Nelson L.; Griffin, Timothy J.

In: Molecular and Cellular Proteomics, Vol. 7, No. 3, 01.03.2008, p. 486-498.

Research output: Contribution to journalArticle

Xie, Hongwei ; Onsongo, Getiria ; Popko, Jonathan ; de Jong, Ebbing P. ; Cao, Jing ; Carlis, John V. ; Griffin, Robert J. ; Rhodus, Nelson L. ; Griffin, Timothy J. / Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. In: Molecular and Cellular Proteomics. 2008 ; Vol. 7, No. 3. pp. 486-498.
@article{25cdc26ee5424fe18a4d7fcbf9a37311,
title = "Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry",
abstract = "Whole human saliva possesses tremendous potential in clinical diagnostics, particularly for conditions within the oral cavity such as oral cancer. Although many have studied the soluble fraction of whole saliva, few have taken advantage of the diagnostic potential of the cells present in saliva, and none have taken advantage of proteomics capabilities for their study. We report on a novel proteomics method with which we characterized for the first time cells contained in whole saliva from patients diagnosed with oral squamous cell carcinoma. Our method uses three dimensions of peptide fractionation, combining the following steps: preparative IEF using free flow electrophoresis, strong cation exchange step gradient chromatography, and microcapillary reverse-phase liquid chromatography. We determined that the whole saliva samples contained enough cells, mostly exfoliated epithelial cells, providing adequate amounts of total protein for proteomics analysis. From a mixture of four oral cancer patient samples, the analysis resulted in a catalogue of over 1000 human proteins, each identified from at least two peptides, including numerous proteins with a role in oral squamous cell carcinoma signaling and tumorigenesis pathways. Additionally proteins from over 30 different bacteria were identified, some of which putatively contribute to cancer development. The combination of preparative IEF followed by strong cation exchange chromatography effectively fractionated the complex peptide mixtures despite the closely related physiochemical peptide properties of these separations (pl and solution phase charge, respectively). Furthermore compared with our two-step method combining preparative IIEF and reverse-phase liquid chromatography, our three-step method identified significantly more cellular proteins while retaining higher confidence protein identification enabled by peptide pl information gained through IEF. Thus, for detecting salivary markers of oral cancer and possibly other conditions of the oral cavity, the results confirm both the potential of analyzing the cells in whole saliva and doing so with our proteomics method.",
author = "Hongwei Xie and Getiria Onsongo and Jonathan Popko and {de Jong}, {Ebbing P.} and Jing Cao and Carlis, {John V.} and Griffin, {Robert J.} and Rhodus, {Nelson L.} and Griffin, {Timothy J.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1074/mcp.M700146-MCP200",
language = "English (US)",
volume = "7",
pages = "486--498",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "3",

}

TY - JOUR

T1 - Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry

AU - Xie, Hongwei

AU - Onsongo, Getiria

AU - Popko, Jonathan

AU - de Jong, Ebbing P.

AU - Cao, Jing

AU - Carlis, John V.

AU - Griffin, Robert J.

AU - Rhodus, Nelson L.

AU - Griffin, Timothy J.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Whole human saliva possesses tremendous potential in clinical diagnostics, particularly for conditions within the oral cavity such as oral cancer. Although many have studied the soluble fraction of whole saliva, few have taken advantage of the diagnostic potential of the cells present in saliva, and none have taken advantage of proteomics capabilities for their study. We report on a novel proteomics method with which we characterized for the first time cells contained in whole saliva from patients diagnosed with oral squamous cell carcinoma. Our method uses three dimensions of peptide fractionation, combining the following steps: preparative IEF using free flow electrophoresis, strong cation exchange step gradient chromatography, and microcapillary reverse-phase liquid chromatography. We determined that the whole saliva samples contained enough cells, mostly exfoliated epithelial cells, providing adequate amounts of total protein for proteomics analysis. From a mixture of four oral cancer patient samples, the analysis resulted in a catalogue of over 1000 human proteins, each identified from at least two peptides, including numerous proteins with a role in oral squamous cell carcinoma signaling and tumorigenesis pathways. Additionally proteins from over 30 different bacteria were identified, some of which putatively contribute to cancer development. The combination of preparative IEF followed by strong cation exchange chromatography effectively fractionated the complex peptide mixtures despite the closely related physiochemical peptide properties of these separations (pl and solution phase charge, respectively). Furthermore compared with our two-step method combining preparative IIEF and reverse-phase liquid chromatography, our three-step method identified significantly more cellular proteins while retaining higher confidence protein identification enabled by peptide pl information gained through IEF. Thus, for detecting salivary markers of oral cancer and possibly other conditions of the oral cavity, the results confirm both the potential of analyzing the cells in whole saliva and doing so with our proteomics method.

AB - Whole human saliva possesses tremendous potential in clinical diagnostics, particularly for conditions within the oral cavity such as oral cancer. Although many have studied the soluble fraction of whole saliva, few have taken advantage of the diagnostic potential of the cells present in saliva, and none have taken advantage of proteomics capabilities for their study. We report on a novel proteomics method with which we characterized for the first time cells contained in whole saliva from patients diagnosed with oral squamous cell carcinoma. Our method uses three dimensions of peptide fractionation, combining the following steps: preparative IEF using free flow electrophoresis, strong cation exchange step gradient chromatography, and microcapillary reverse-phase liquid chromatography. We determined that the whole saliva samples contained enough cells, mostly exfoliated epithelial cells, providing adequate amounts of total protein for proteomics analysis. From a mixture of four oral cancer patient samples, the analysis resulted in a catalogue of over 1000 human proteins, each identified from at least two peptides, including numerous proteins with a role in oral squamous cell carcinoma signaling and tumorigenesis pathways. Additionally proteins from over 30 different bacteria were identified, some of which putatively contribute to cancer development. The combination of preparative IEF followed by strong cation exchange chromatography effectively fractionated the complex peptide mixtures despite the closely related physiochemical peptide properties of these separations (pl and solution phase charge, respectively). Furthermore compared with our two-step method combining preparative IIEF and reverse-phase liquid chromatography, our three-step method identified significantly more cellular proteins while retaining higher confidence protein identification enabled by peptide pl information gained through IEF. Thus, for detecting salivary markers of oral cancer and possibly other conditions of the oral cavity, the results confirm both the potential of analyzing the cells in whole saliva and doing so with our proteomics method.

UR - http://www.scopus.com/inward/record.url?scp=41549114532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41549114532&partnerID=8YFLogxK

U2 - 10.1074/mcp.M700146-MCP200

DO - 10.1074/mcp.M700146-MCP200

M3 - Article

C2 - 18045803

AN - SCOPUS:41549114532

VL - 7

SP - 486

EP - 498

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 3

ER -